One has to wonder who checks the costing that Novartis uses to justify the price of its Kymriah Cancer Drug. What would Robert Koch, Louis Pasteur or Alexander Fleming make of this behaviour?
https://www.bloomberg.com//news/articles/2017-08-30/cancer-breakthrough-heralds-new-era-of-cures-costs-and-choices
I asked Grok for Its Opinion on “Grok vs ChatGPT, Which Is Better?”
-
Let's compare Google AI's answer to Grok's.
11 hours ago
No comments:
Post a Comment